A Study to Validate the Rationale and Efficacy of a Pre-emptive approach to the management of Cytomegalovirus (CMV) reactivation post allogeneic haematopoietic stem cell transplantation (HSCT)

被引：0
|
作者：
Farah, N. [1 ]
Szydlo, R. [1 ]
Mitul, P. [1 ]
Sridharan, M. [1 ]
Sawhney, H. [1 ]
Lasa, M. [1 ]
Mccue, J. [1 ]
Atkins, M. [1 ]
Kanfer, E. [1 ]
MacDonald, D. [1 ]
Milojkovic, D. [1 ]
Pavlu, J. [1 ]
Olavarria, E. [1 ]
Rahemtulla, A. [1 ]
Chaidos, A. [1 ]
Gabriel, I. [1 ]
Apperley, J. [1 ]
机构：
[1] Imperial Coll Healthcare NHS Trust, London, England
来源：
BONE MARROW TRANSPLANTATION | 2015年 / 50卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P578
引用
收藏
页码：S409 / S410
页数：2
相关论文
共 50 条
  • [1] Pre-emptive therapy with valganciclovir for cytomegalovirus (CMV) infection after allogeneic haematopoietic stem cell transplantation (Allo-HSCT)
    Topcuoglu, P.
    Arslan, O.
    Ozcan, M.
    Ilhan, O.
    Akan, H.
    Uysal, A.
    Gurman, G.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S322 - S323
  • [2] Oral valganciclovir as pre-emptive therapy for CMV infection post allogeneic haematopoietic stem cell transplantation
    Busca, A
    Locatelli, F
    Ceretto, C
    Ghisetti, V
    de Fabritiis, P
    Mirabile, M
    Gentile, G
    Falda, M
    BONE MARROW TRANSPLANTATION, 2006, 37 : S188 - S188
  • [3] Valganciclovir is safe and effective as pre-emptive treatment for CMV reactivation in allogeneic hematopoietic stem cell transplantation
    Pastano, R.
    Gigli, F.
    Andreola, G.
    Peccatori, F. A.
    Martinelli, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 468 - 468
  • [4] Cidofovir (CDV) as prophylaxis and pre-emptive therapy of Cytomegalovirus (CMV) infection in allogeneic stem cell transplantation
    Cudillo, L
    Dentamaro, T
    Postorino, M
    Picardi, A
    Rainaldi, A
    Cupelli, L
    De Laurenzi, F
    Di Caro, A
    Amadori, S
    BONE MARROW TRANSPLANTATION, 2001, 27 : S153 - S153
  • [5] Foscarnet as single agent pre-emptive treatment of cytomegalovirus reactivation after T-cell depleted allogeneic haematopoietic stem cell transplantation
    Ciceri, F
    Lunghi, F
    Pescarollo, A
    Guggiari, E
    Bonini, C
    Servida, P
    Callegaro, L
    Bernardi, M
    Crippa, F
    Bordignon, C
    Bregni, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S319 - S319
  • [6] Pre-emptive treatment with rituximab for Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation: a safety and efficacy study
    Ganguly, S.
    DuBois, L.
    Divine, C.
    Aljitawi, O.
    Abhyankar, S.
    McGuirk, J.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S225 - S225
  • [7] Assessment of efficacy and renal toxicity of pre-emptive therapy for CMV reactivation in paediatric patients who underwent allogeneic stem cell transplantation
    Cesaro, S
    Calò, A
    Pillon, M
    Tridello, G
    Varotto, S
    Calore, E
    Mengoli, C
    Cusinato, R
    Messina, C
    BONE MARROW TRANSPLANTATION, 2006, 37 : S170 - S170
  • [8] Risk factors of CMV reactivation post allogeneic haematopoietic stem cell transplantation
    Jaskula, E.
    Drabczak-Skrzypek, D.
    Mlynarczewska, A.
    Sedzimirska, M.
    Bogunia-Kubik, K.
    Lange, A.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S267 - S267
  • [9] Pre-emptive treatment for EBV reactivation after allogeneic haematopoietic stem cells transplantation: An effective strategy
    Ahmad, I.
    Van, C. Nguyen
    Bennani, J.
    Kwan, J.
    Aoun, M.
    Lewalle, P.
    Meuleman, N.
    Martiat, P.
    Bron, D.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S161 - S161
  • [10] Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients
    Ruiz-Camps, Isabel
    Len, Oscar
    de la Camara, Rafael
    Gurgui, Mercedes
    Martino, Rodrigo
    Jarque, Isidro
    Barrenetxea, Cristina
    Diaz de Heredia, Cristina
    Batlle, Montserrat
    Rovira, Montserrat
    de la Torre, Julian
    Torres, Antonio
    Aguilar, Manuela
    Espigado, Ildefonso
    Martin-Davila, Pilar
    Bou, German
    Borrell, Nuria
    Maria Aguado, Jose
    Pahissa, Albert
    ANTIVIRAL THERAPY, 2011, 16 (07) : 951 - 957
12345